MOH Quote, Financials, Valuation and Earnings

The Cigna Group has a net margin of 2.67% compared to Molina Healthcare's net margin of 2.02%. Molina Healthcare's return on equity of 25.66% beat The Cigna Group's return on equity of 12.17%.

Molina Healthcare has a consensus price target of $359.49, signalling upside risk potential of 20.58%. On the other hand The Cigna Group has an analysts' consensus of $375.34 which suggests that it could grow by 18.25%. Given that Molina Healthcare has higher upside potential than The Cigna Group, analysts believe Molina Healthcare is more attractive than The Cigna Group.

Molina Healthcare has a beta of 0.564, which suggesting that the stock is 43.589% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.437, suggesting its less volatile than the S&P 500 by 56.294%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cigna Group offers a yield of 1.83% to investors and pays a quarterly dividend of $1.51 per share. Molina Healthcare pays -- of its earnings as a dividend. The Cigna Group pays out 45.63% of its earnings as a dividend. The Cigna Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare quarterly revenues are $11.1B, which are smaller than The Cigna Group quarterly revenues of $65.5B. Molina Healthcare's net income of $298M is lower than The Cigna Group's net income of $1.3B. Notably, Molina Healthcare's price-to-earnings ratio is 14.40x while The Cigna Group's PE ratio is 17.57x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.40x versus 0.35x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.

Centene has a net margin of 2.67% compared to Molina Healthcare's net margin of 2.81%. Molina Healthcare's return on equity of 25.66% beat Centene's return on equity of 12.65%.

Molina Healthcare has a consensus price target of $359.49, signalling upside risk potential of 20.58%. On the other hand Centene has an analysts' consensus of $76.50 which suggests that it could grow by 38.54%. Given that Centene has higher upside potential than Molina Healthcare, analysts believe Centene is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.564, which suggesting that the stock is 43.589% less volatile than S&P 500. In comparison Centene has a beta of 0.453, suggesting its less volatile than the S&P 500 by 54.716%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Molina Healthcare pays -- of its earnings as a dividend. Centene pays out -- of its earnings as a dividend.

Molina Healthcare quarterly revenues are $11.1B, which are smaller than Centene quarterly revenues of $46.6B. Molina Healthcare's net income of $298M is lower than Centene's net income of $1.3B. Notably, Molina Healthcare's price-to-earnings ratio is 14.40x while Centene's PE ratio is 8.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.40x versus 0.17x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health has a net margin of 2.67% compared to Molina Healthcare's net margin of 4.47%. Molina Healthcare's return on equity of 25.66% beat Elevance Health's return on equity of 14.03%.

Molina Healthcare has a consensus price target of $359.49, signalling upside risk potential of 20.58%. On the other hand Elevance Health has an analysts' consensus of $500.75 which suggests that it could grow by 30.22%. Given that Elevance Health has higher upside potential than Molina Healthcare, analysts believe Elevance Health is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.564, which suggesting that the stock is 43.589% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.603, suggesting its less volatile than the S&P 500 by 39.674%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health offers a yield of 1.74% to investors and pays a quarterly dividend of $1.71 per share. Molina Healthcare pays -- of its earnings as a dividend. Elevance Health pays out 25.22% of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare quarterly revenues are $11.1B, which are smaller than Elevance Health quarterly revenues of $48.9B. Molina Healthcare's net income of $298M is lower than Elevance Health's net income of $2.2B. Notably, Molina Healthcare's price-to-earnings ratio is 14.40x while Elevance Health's PE ratio is 15.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.40x versus 0.49x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of 2.67% compared to Molina Healthcare's net margin of 5.74%. Molina Healthcare's return on equity of 25.66% beat UnitedHealth Group's return on equity of 21.74%.

Molina Healthcare has a consensus price target of $359.49, signalling upside risk potential of 20.58%. On the other hand UnitedHealth Group has an analysts' consensus of $385.34 which suggests that it could grow by 22.9%. Given that UnitedHealth Group has higher upside potential than Molina Healthcare, analysts believe UnitedHealth Group is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.564, which suggesting that the stock is 43.589% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.442, suggesting its less volatile than the S&P 500 by 55.841%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 2.68% to investors and pays a quarterly dividend of $2.21 per share. Molina Healthcare pays -- of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare quarterly revenues are $11.1B, which are smaller than UnitedHealth Group quarterly revenues of $109.6B. Molina Healthcare's net income of $298M is lower than UnitedHealth Group's net income of $6.3B. Notably, Molina Healthcare's price-to-earnings ratio is 14.40x while UnitedHealth Group's PE ratio is 13.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.40x versus 0.71x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.